Review on the current use of antipsychotic drugs in children and adolescents

被引:24
作者
Almandil, Noor B. [2 ]
Wong, Ian C. K. [1 ,2 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Pokfulam, Hong Kong, Peoples R China
[2] Univ London, Sch Pharm, Ctr Paediat Pharm Res, London WC1N 1AX, England
来源
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION | 2011年 / 96卷 / 05期
关键词
EARLY-ONSET SCHIZOPHRENIA; SPECTRUM DISORDERS TEOSS; DOUBLE-BLIND; 2ND-GENERATION ANTIPSYCHOTICS; PSYCHOTROPIC MEDICATIONS; ATYPICAL ANTIPSYCHOTICS; OPEN-LABEL; RISPERIDONE; SAFETY; TOLERABILITY;
D O I
10.1136/archdischild-2011-300054
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Antipsychotic (neuroleptic) drugs are used in the treatment of various psychiatric disorders in children and adolescents. There is a lack of information about the efficacy and safety of antipsychotics in young people. Much of the information available is extrapolated from adult studies; in particular, little is known about the long-term effects of these drugs on the development of the central nervous system. Over the last two decades, typical antipsychotics have largely been replaced by atypical antipsychotics. With this increase in use of atypical antipsychotic drugs, there has been growing concern about the appropriate use of these drugs and the fact that they appear to be associated with metabolic abnormalities such as weight gain, diabetes and related cardiovascular effects. This paper provides a review of current practice and evidence based use of antipsychotic drugs in children.
引用
收藏
页码:192 / 196
页数:5
相关论文
共 42 条
  • [31] National trends in the outpatient treatment of children and adolescents with antipsychotic drugs
    Olfson, Mark
    Blanco, Carlos
    Liu, Linxu
    Moreno, Carmen
    Laje, Gonzalo
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (06) : 679 - 685
  • [32] OPINION Why do many psychiatric disorders emerge during adolescence?
    Paus, Tomas
    Keshavan, Matcheri
    Giedd, Jay N.
    [J]. NATURE REVIEWS NEUROSCIENCE, 2008, 9 (12) : 947 - 957
  • [33] Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom
    Rani, Fariz
    Murray, Macey L.
    Byrne, Patrick J.
    Wong, Ian C. K.
    [J]. PEDIATRICS, 2008, 121 (05) : 1002 - 1009
  • [34] Paediatric Atypical Antipsychotic Monitoring Safety (PAMS) Study Pilot Study in Children and Adolescents in Secondary- and Tertiary-Care Settings
    Rani, Fariz A.
    Byrne, Patrick J.
    Murray, Macey L.
    Carter, Paul
    Wong, Ian C. K.
    [J]. DRUG SAFETY, 2009, 32 (04) : 325 - 333
  • [35] *ROYAL COLL PAED C, 2009, BRIT NAT FORM CHILDR
  • [36] Childhood-onset schizophrenia - A double-blind, randomized clozapine-olanzapine comparison
    Shaw, Philip
    Sporn, Alex
    Gogtay, Nitin
    Overman, Gerald P.
    Greenstein, Deanna
    Gochman, Peter
    Tossell, Julia W.
    Lenane, Marge
    Rapoport, Judith L.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (07) : 721 - 730
  • [37] Sikich L, 2008, AM J PSYCHIAT, V165, P1420, DOI 10.1176/appi.ajp.2008.08050756
  • [38] Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs
    Snyder, R
    Turgay, A
    Aman, M
    Binder, C
    Fisman, S
    Carroll, A
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (09) : 1026 - 1036
  • [39] Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns
    Vitiello, Benedetto
    Correll, Christoph
    van Zwieten-Boot, Barbara
    Zuddas, Alessandro
    Parellada, Mara
    Arango, Celso
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (09) : 629 - 635
  • [40] Increased prescribing trends of paediatric psychotropic medications
    Wong, ICK
    Murray, ML
    Novak, DC
    Stephens, P
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (12) : 1131 - 1132